本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Travere Therapeutics, Inc.

16.11
-0.4000-2.42%
盤後16.110.00000.00%16:33 EDT
成交量:144.38萬
成交額:2,354.24萬
市值:14.31億
市盈率:-5.81
高:16.74
開:16.65
低:16.10
收:16.51
資料載入中...
2023/05/04

重要事件披露

8-K - Current report
2023/05/04

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/05/01

重要事件披露

Form 8-K - Current report
2023/04/12

重要事件披露

8-K - Current report
2023/03/13

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/03/01

[補充]招股説明書

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2023/03/01

重要事件披露

8-K - Current report
2023/02/23

重要事件披露

8-K - Current report
2023/02/23

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/02/17

重要事件披露

8-K - Current report
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/09

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/09

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/01/09

重要事件披露

8-K - Current report
2022/10/28

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/10/27

重要事件披露

8-K - Current report
2022/10/27

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]